Skip to main content
Future Medicine Co., Ltd. logo

Future Medicine Co., Ltd. - Investor Relations & Filings

Listed IPO Jul 2022
Ticker · 341170 ISIN · KR7341170009 KO Manufacturing
Open in API
Filings indexed 100 across all filing types
Latest filing 2025-03-28 Declaration of Voting R…
Country KR South Korea
Listing KO 341170 · 1 venue

About Future Medicine Co., Ltd.

http://futuremedicine.co.kr/

Future Medicine Co., Ltd. is a new drug development company specializing in nucleoside-based synthetic drugs. The company focuses on creating therapeutics for diseases with high unmet medical needs, particularly in antiviral and anticancer applications. Its primary pipeline candidate, FM101, is an anti-inflammatory and anti-fibrotic agent being investigated for the treatment of conditions such as non-alcoholic steatohepatitis (NASH), diabetic nephropathy, and primary biliary cholangitis (PBC). The company has also conducted research and filed patents for therapeutics related to coronaviruses.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This document is an official record of the voting outcomes and decisions made at the AGM, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements'.
2025-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of an outside director. This type of corporate governance disclosure specifically relates to changes in the board of directors, which falls under the 'Board/Management Information' category.
2025-03-28 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal announcement titled 'Audit Report Submission' (감사보고서 제출) from Future Medicine. It provides a summary of the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, net income), and auditor information. While it contains financial data, it is a regulatory disclosure announcement regarding the filing of the audit report rather than the full annual report itself. According to the 'Menu vs Meal' rule, this is a report publication announcement. FY 2024
2025-03-20 Korean
사업보고서 (2024.12)
Interim / Quarterly Report Classification · 95% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Future Medicine Co., Ltd. for the fiscal year ending December 31, 2024. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This is a comprehensive annual financial report for a period shorter than a full fiscal year or a full fiscal year report that is not a 10-K (as it is a Korean entity filing under K-IFRS). Given the definition provided, this document constitutes an Interim/Quarterly Report (IR) or Annual Report. Since it covers the full fiscal year 2024 and contains full financial statements, it is classified as an Interim/Quarterly Report (IR) in the context of the provided categories, as it is the primary financial reporting document. FY 2024
2025-03-20 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Future Medicine Co., Ltd. It contains the meeting agenda, details on board activities, and preliminary financial statements for the 10th fiscal year. This document is a standard proxy statement/information circular provided to shareholders to inform them of the upcoming AGM and solicit their votes on specific agenda items (such as financial statement approval, director appointments, and remuneration).
2025-03-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집 결의) issued by Future Medicine. It outlines the date, location, and agenda items (financial statements, articles of incorporation changes, director appointments, and remuneration limits). This type of document is a standard proxy solicitation material sent to shareholders to inform them of upcoming meeting details and request their participation/votes, which aligns with the Proxy Solicitation & Information Statement category.
2025-03-13 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.